# TNF in Melanoma Patients Treated With Immunotherapy

> **NCT03348891** · NA · COMPLETED · sponsor: **Institut Claudius Regaud** · enrollment: 60 (actual)

## Conditions studied

- Melanoma

## Interventions

- **OTHER:** Tumor biopsy specimens and blood samples

## Key facts

- **NCT ID:** NCT03348891
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-05
- **Primary completion:** 2021-03-03
- **Final completion:** 2021-11-22
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03348891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03348891, "TNF in Melanoma Patients Treated With Immunotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03348891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*